Implication of hepatic transporters (MDR1 and MRP2) in inflammation-associated idiosyncratic drug-induced hepatotoxicity investigated by microvolume cytometry
Open Access
- 11 February 2013
- journal article
- research article
- Published by Wiley in Cytometry Part A
- Vol. 83A (4) , 403-408
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Idiosyncratic Drug-Induced Liver Injury and the Role of Inflammatory Stress with an Emphasis on an Animal Model of Trovafloxacin HepatotoxicityToxicological Sciences, 2010
- Regulation of human hepatic drug transporter expression by pro-inflammatory cytokinesExpert Opinion on Drug Metabolism & Toxicology, 2009
- Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal ModelsPharmacological Reviews, 2009
- Current Concepts of Mechanisms in Drug-Induced HepatotoxicityCurrent Medicinal Chemistry, 2009
- Synergistic drug–cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicityToxicology and Applied Pharmacology, 2009
- Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and CancerDrug Metabolism and Disposition, 2008
- Regulation of Transporters by Nuclear Hormone Receptors: Implications during InflammationMolecular Pharmaceutics, 2007
- Microarray Analysis of Lipopolysaccharide Potentiation of Trovafloxacin-Induced Liver Injury in Rats Suggests a Role for Proinflammatory Chemokines and NeutrophilsThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Inhibition of Hepatobiliary Transport as a Predictive Method for Clinical Hepatotoxicity of NefazodoneToxicological Sciences, 2006
- Involvement of the Drug Transporters P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2 in Telithromycin TransportAntimicrobial Agents and Chemotherapy, 2006